世界の経カテーテル心臓弁置換及び修復術市場2023-2031:処置別(大動脈弁置換術、僧帽弁修復術、肺動脈弁置換術)

【英語タイトル】Transcatheter Heart Valve Replacement & Repair Market (Procedure: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair, and Transcatheter Pulmonary Valve Replacement) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが出版した調査資料(TMR23MA152)・商品コード:TMR23MA152
・発行会社(調査会社):Transparency Market Research
・発行日:2023年3月14日
・ページ数:235
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(納期はお問い合わせください。)
・調査対象地域:北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥880,840見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD8,795 ⇒換算¥1,336,840見積依頼/購入/質問フォーム
Corporate License(法人閲覧)USD11,795 ⇒換算¥1,792,840見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートによると、世界の経カテーテル心臓弁置換及び修復術市場規模が、2023年の34億ドルから2031年には80億ドルまで年平均9.7%成長すると展望されています。本レポートは経カテーテル心臓弁置換及び修復術の世界市場について広く調査・分析し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、処置別(大動脈弁置換術、僧帽弁修復術、肺動脈弁置換術)分析、疾患別(大動脈弁狭窄症、僧帽弁閉鎖不全症、大動脈弁逆流、僧帽弁狭窄症、その他)分析、エンドユーザー別(病院、心臓カテーテル研究所、外来手術センター)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、競争状況、主要ポイントなどを整理しています。なお、本資料には、Abbott Laboratories、Edwards Lifesciences Corporation、Medtronic plc、Boston Scientific Corporation、JenaValve Technology, Inc.、Meril Life Sciences、Sahajanand Medical Technologies Limited、MicroPort Scientific Corporation、Venus Medtech (Hangzhou) Inc.、Suzhou Jiecheng Medical Technology Co. Ltd.などの企業情報が含まれています。
・序論
・仮定
・調査方法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症分析
・世界の経カテーテル心臓弁置換及び修復術市場規模:処置別
- 経カテーテル大動脈弁置換術の市場規模
- 経カテーテル僧帽弁修復術の市場規模
- 経カテーテル肺動脈弁置換術の市場規模
・世界の経カテーテル心臓弁置換及び修復術市場規模:疾患別
- 大動脈弁狭窄症の市場規模
- 僧帽弁閉鎖不全症の市場規模
- 大動脈弁逆流の市場規模
- 僧帽弁狭窄症の市場規模
- その他疾患の市場規模
・世界の経カテーテル心臓弁置換及び修復術市場規模:エンドユーザー別
- 病院における市場規模
- 心臓カテーテル研究所における市場規模
- 外来手術センターにおける市場規模
・世界の経カテーテル心臓弁置換及び修復術市場規模:地域別
- 北米の経カテーテル心臓弁置換及び修復術市場規模
- 中南米の経カテーテル心臓弁置換及び修復術市場規模
- ヨーロッパの経カテーテル心臓弁置換及び修復術市場規模
- アジア太平洋の経カテーテル心臓弁置換及び修復術市場規模
- 中東・アフリカの経カテーテル心臓弁置換及び修復術市場規模
・競争状況
・企業情報
・主要ポイント

Transcatheter Heart Valve Replacement & Repair Market – Scope of Report
TMR’s report on the global transcatheter heart valve replacement & repair market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transcatheter heart valve replacement & repair market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transcatheter heart valve replacement & repair market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the transcatheter heart valve replacement & repair market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transcatheter heart valve replacement & repair market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transcatheter heart valve replacement & repair market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transcatheter heart valve replacement & repair market.

The report delves into the competitive landscape of the global transcatheter heart valve replacement & repair market. Key players operating in the global transcatheter heart valve replacement & repair market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transcatheter heart valve replacement & repair market profiled in this report.

Key Questions Answered in Global Transcatheter Heart Valve Replacement & Repair Market Report
• What is the sales/revenue generated by transcatheter heart valve replacement & repair across all regions during the forecast period?
• What are the opportunities in the global transcatheter heart valve replacement & repair market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Transcatheter Heart Valve Replacement & Repair Market – Research Objectives and Research Approach
The comprehensive report on the global transcatheter heart valve replacement & repair market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transcatheter heart valve replacement & repair market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transcatheter heart valve replacement & repair market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transcatheter Heart Valve Replacement & Repair Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Technological Advancements
    5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
    5.3. Key Industry Events
    5.4. COVID-19 Impact Analysis
6. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Procedure
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Procedure, 2017–2031
        6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
        6.3.2. Transcatheter Mitral Valve Repair (TMVR)
        6.3.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    6.4. Market Attractiveness Analysis, by Procedure
7. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Indication
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Indication, 2017–2031
        7.3.1. Aortic Stenosis
        7.3.2. Mitral Regurgitation
        7.3.3. Aortic Regurgitation
        7.3.4. Mitral Stenosis
        7.3.5. Tricuspid Regurgitation
    7.4. Market Attractiveness Analysis, by Indication
8. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Cardiac Catheterization Laboratories
        8.3.3. Ambulatory Surgical Centers
    8.4. Market Attractiveness Analysis, by End-user
9. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Procedure, 2017–2031
        10.2.1. Transcatheter Aortic Valve Replacement (TAVR)
        10.2.2. Transcatheter Mitral Valve Repair (TMVR)
        10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    10.3. Market Value Forecast, by Indication, 2017–2031
        10.3.1. Aortic Stenosis
        10.3.2. Mitral Regurgitation
        10.3.3. Aortic Regurgitation
        10.3.4. Mitral Stenosis
        10.3.5. Tricuspid Regurgitation
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Cardiac Catheterization Laboratories
        10.4.3. Ambulatory Surgical Centers
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Procedure
        10.6.2. By Indication
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Procedure, 2017–2031
        11.2.1. Transcatheter Aortic Valve Replacement (TAVR)
        11.2.2. Transcatheter Mitral Valve Repair (TMVR)
        11.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    11.3. Market Value Forecast, by Indication, 2017–2031
        11.3.1. Aortic Stenosis
        11.3.2. Mitral Regurgitation
        11.3.3. Aortic Regurgitation
        11.3.4. Mitral Stenosis
        11.3.5. Tricuspid Regurgitation
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Cardiac Catheterization Laboratories
        11.4.3. Ambulatory Surgical Centers
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Procedure
        11.6.2. By Indication
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Procedure, 2017–2031
        12.2.1. Transcatheter Aortic Valve Replacement (TAVR)
        12.2.2. Transcatheter Mitral Valve Repair (TMVR)
        12.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    12.3. Market Value Forecast, by Indication, 2017–2031
        12.3.1. Aortic Stenosis
        12.3.2. Mitral Regurgitation
        12.3.3. Aortic Regurgitation
        12.3.4. Mitral Stenosis
        12.3.5. Tricuspid Regurgitation
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Cardiac Catheterization Laboratories
        12.4.3. Ambulatory Surgical Centers
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Procedure
        12.6.2. By Indication
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Procedure, 2017–2031
        13.2.1. Transcatheter Aortic Valve Replacement (TAVR)
        13.2.2. Transcatheter Mitral Valve Repair (TMVR)
        13.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    13.3. Market Value Forecast, by Indication, 2017–2031
        13.3.1. Aortic Stenosis
        13.3.2. Mitral Regurgitation
        13.3.3. Aortic Regurgitation
        13.3.4. Mitral Stenosis
        13.3.5. Tricuspid Regurgitation
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Cardiac Catheterization Laboratories
        13.4.3. Ambulatory Surgical Centers
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Procedure
        13.6.2. By Indication
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Procedure, 2017–2031
        14.2.1. Transcatheter Aortic Valve Replacement (TAVR)
        14.2.2. Transcatheter Mitral Valve Repair (TMVR)
        14.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
    14.3. Market Value Forecast, by Indication, 2017–2031
        14.3.1. Aortic Stenosis
        14.3.2. Mitral Regurgitation
        14.3.3. Aortic Regurgitation
        14.3.4. Mitral Stenosis
        14.3.5. Tricuspid Regurgitation
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Cardiac Catheterization Laboratories
        14.4.3. Ambulatory Surgical Centers
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Procedure
        14.6.2. By Indication
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Abbott Laboratories
            15.3.1.1. Company Overview
            15.3.1.2. Procedure Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Edwards Lifesciences Corporation
            15.3.2.1. Company Overview
            15.3.2.2. Procedure Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Boston Scientific Corporation
            15.3.3.1. Company Overview
            15.3.3.2. Procedure Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. B. Braun Melsungen AG
            15.3.4.1. Company Overview
            15.3.4.2. Procedure Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Medtronic plc
            15.3.5.1. Company Overview
            15.3.5.2. Procedure Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Meril Life Sciences
            15.3.6.1. Company Overview
            15.3.6.2. Procedure Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Sahajanand Medical Technologies Limited
            15.3.7.1. Company Overview
            15.3.7.2. Procedure Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. MicroPort Scientific Corporation
            15.3.8.1. Company Overview
            15.3.8.2. Procedure Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Venus Medtech (Hangzhou) Inc.
            15.3.9.1. Company Overview
            15.3.9.2. Procedure Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
        15.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
            15.3.10.1. Company Overview
            15.3.10.2. Procedure Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Financial Overview
            15.3.10.5. Strategic Overview
        15.3.11. Peijia Medical Limited
            15.3.11.1. Company Overview
            15.3.11.2. Procedure Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Financial Overview
            15.3.11.5. Strategic Overview
        15.3.12. Blue Sail Medical Co., Ltd.
            15.3.12.1. Company Overview
            15.3.12.2. Procedure Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Financial Overview
            15.3.12.5. Strategic Overview



★調査レポート[世界の経カテーテル心臓弁置換及び修復術市場2023-2031:処置別(大動脈弁置換術、僧帽弁修復術、肺動脈弁置換術)] (コード:TMR23MA152)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経カテーテル心臓弁置換及び修復術市場2023-2031:処置別(大動脈弁置換術、僧帽弁修復術、肺動脈弁置換術)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆